Literature DB >> 3312788

Insulin binding to erythrocytes in hyperinsulinemic patients with precirrhotic hemochromatosis and cirrhosis.

A S Petrides1, W Passlack, H Reinauer, W Stremmel, G Strohmeyer.   

Abstract

This study investigated insulin receptor binding (number and affinity) to erythrocytes in patients with precirrhotic hemochromatosis, patients with cirrhosis, and healthy subjects. To evaluate plasma glucose and insulin levels, an oral glucose tolerance test (OGTT) was performed in all subjects. In the fasting state, all patients exhibited normal glucose levels. Precirrhotic patients showed slight impairment of glucose tolerance while cirrhotic patients were strikingly glucose intolerant. In both patient groups, fasting plasma insulin levels were increased. Following the glucose load, plasma insulin levels were significantly enhanced in precirrhotic patients at 90 and 120 min and increased at all times in cirrhotic patients. In the postabsorptive state (in the presence of hyperinsulinemia) insulin binding and the number and affinity of insulin receptors of erythrocytes were not different in precirrhotic or cirrhotic patients when compared to controls. We conclude that studies of insulin binding on erythrocytes do not contribute to the evaluation of the pathogenesis of insulin resistance in liver disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312788     DOI: 10.1007/BF01737009

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  27 in total

1.  Characteristics of the human lymphocyte insulin receptor.

Authors:  J R Gavin; P Gorden; J Roth; J A Archer; D N Buell
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

2.  Glucose intolerance in liver cirrhosis.

Authors:  O Riggio; M Merli; C Cangiano; R Capocaccia; A Cascino; A Lala; F Leonetti; M Mauceri; M Pepe; F Rossi Fanelli; M Savioli; G Tamburrano; L Capocaccia
Journal:  Metabolism       Date:  1982-06       Impact factor: 8.694

3.  Erythrocyte insulin receptors in patients with chronic liver diseases.

Authors:  S Fujita; T Takimoto; M Kobayashi; Y Shigeta; M Hoshi
Journal:  Horm Metab Res       Date:  1982-01       Impact factor: 2.936

4.  Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

5.  Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?

Authors:  C Niederau; M Berger; W Stremmel; A Starke; G Strohmeyer; R Ebert; E Siegel; W Creutzfeldt
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

6.  [Insulin resistance in liver diseases].

Authors:  A S Petrides; G Strohmeyer
Journal:  Z Gastroenterol       Date:  1986-08       Impact factor: 2.000

7.  Direct evidence for downregulation of insulin receptors by physiologic hyperinsulinemia in man.

Authors:  V R Soman; R A DeFronzo
Journal:  Diabetes       Date:  1980-02       Impact factor: 9.461

8.  Insulin resistance in liver cirrhosis: decreased insulin binding to circulating monocytes.

Authors:  A V Greco; A Bertoli; G Ghirlanda; R Manna; L Altomonte; A G Rebuzzi
Journal:  Horm Metab Res       Date:  1980-11       Impact factor: 2.936

9.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

Authors:  O G Kolterman; R S Gray; J Griffin; P Burstein; J Insel; J A Scarlett; J M Olefsky
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

10.  Insulin resistance and insulin receptors in hepatic cirrhosis.

Authors:  A T Blei; D C Robbins; E Drobny; G Baumann; A H Rubenstein
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

View more
  2 in total

1.  Hepatic kinome atlas: An in-depth identification of kinase pathways in liver fibrosis of humans and rodents.

Authors:  Justin F Creeden; Zachary A Kipp; Mei Xu; Robert M Flight; Hunter N B Moseley; Genesee J Martinez; Wang-Hsin Lee; Khaled Alganem; Ali S Imami; Megan R McMullen; Sanjoy Roychowdhury; Atta M Nawabi; Jennifer A Hipp; Samir Softic; Steven A Weinman; Robert McCullumsmith; Laura E Nagy; Terry D Hinds
Journal:  Hepatology       Date:  2022-04-08       Impact factor: 17.298

Review 2.  Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.

Authors:  Olufunto O Badmus; Sarah A Hillhouse; Christopher D Anderson; Terry D Hinds; David E Stec
Journal:  Clin Sci (Lond)       Date:  2022-09-30       Impact factor: 6.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.